Alhemo® is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A with Factor 8 inhibitors or hemophilia B with Factor 9 inhibitors. It is not known if Alhemo® is safe and effective in people younger than 12 years of age or in people receiving ongoing immune tolerance induction (ITI).
Your zip code is . Not correct? Change ZIP. Apply new ZIP code.
Hello! I look forward to connecting with you. Please provide the following information and I’ll be in touch:
is not a valid ZIP code
A valid ZIP code will have 5 numbers. Please try again.
Please enter a valid ZIP code.
Technical error
We are experiencing an unexpected technical error. Please try again later.
Please enter your zip code
Please try again.
Do not use Alhemo® if you are allergic to concizumab-mtci or any of the ingredients in Alhemo®.
Before using Alhemo®, tell your HCP about all of your medical conditions, including if you:
Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your HCP and pharmacist when you get a new medicine.
Alhemo® may cause serious side effects, including:
The most common side effects of Alhemo® include: bruising, redness, bleeding, or itching at the site of injection, and hives.
Please see Prescribing Information and Medication Guide for Alhemo®.
Alhemo® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, or 300 mg is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.
Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, or 300 mg is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.
Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, or 300 mg is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.
Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, or 300 mg is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.
Do not use Alhemo® if you are allergic to concizumab-mtci or any of the ingredients in Alhemo®.
Do not use Alhemo® if you are allergic to concizumab-mtci or any of the ingredients in Alhemo®.
Before using Alhemo®, tell your HCP about all of your medical conditions, including if you:
Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your HCP and pharmacist when you get a new medicine.
Alhemo® may cause serious side effects, including:
The most common side effects of Alhemo® include: bruising, redness, bleeding, or itching at the site of injection, and hives.
Please see Prescribing Information and Medication Guide for Alhemo®.
Alhemo® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Do not use Alhemo® if you are allergic to concizumab-mtci or any of the ingredients in Alhemo®.
Before using Alhemo®, tell your HCP about all of your medical conditions, including if you:
Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your HCP and pharmacist when you get a new medicine.
Alhemo® may cause serious side effects, including:
The most common side effects of Alhemo® include: bruising, redness, bleeding, or itching at the site of injection, and hives.
Please see Prescribing Information and Medication Guide for Alhemo®.
Alhemo® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, or 300 mg is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.
Alhemo® (concizumab-mtci) injection 60 mg, 150 mg, or 300 mg is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.
Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Alhemo® is a registered trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2024 Novo Nordisk All rights reserved. US24AHM00044 December 2024
You are about to leave alhemo.com, a Novo Nordisk website
Click “Continue” to leave this site and come back to visit us another time. Click “Return to site” to stay and learn more about Alhemo.
You are about to leave alhemo.com, a Novo Nordisk website
Click “Continue” to leave this website. Novo Nordisk is not responsible for content that follows. Please come back to visit us another time.
Click “Return to site” to stay and learn more about Alhemo.